| 2023 |
| 10/06 | 1,795 | 1,795 | 1,776 | 1,776 | -1.06% | 22,300 | 219億1293万 | -4.98% |
| 10/05 | 1,795 | 1,805 | 1,769 | 1,795 | +2.28% | 59,400 | 221億4736万 | -4.06% |
| 10/04 | 1,789 | 1,798 | 1,753 | 1,755 | -3.36% | 76,300 | 216億5383万 | -6.25% |
| 10/03 | 1,851 | 1,860 | 1,812 | 1,816 | -2% | 56,100 | 224億647万 | -3.2% |
| 10/02 | 1,891 | 1,907 | 1,853 | 1,853 | -2.47% | 39,700 | 228億6299万 | -1.23% |
| 09/29 | 1,919 | 1,919 | 1,882 | 1,900 | -0.52% | 28,600 | 234億4289万 | +1.33% |
| 09/28 | 1,902 | 1,925 | 1,900 | 1,910 | -0.57% | 40,900 | 235億6627万 | +2.08% |
| 09/27 | 1,902 | 1,921 | 1,888 | 1,921 | +1.64% | 47,300 | 237億199万 | +2.84% |
| 09/26 | 1,892 | 1,900 | 1,882 | 1,890 | -0.11% | 23,000 | 233億1950万 | +1.39% |
| 09/25 | 1,868 | 1,897 | 1,868 | 1,892 | +1.23% | 20,500 | 233億4418万 | +1.67% |
| 09/22 | 1,840 | 1,882 | 1,831 | 1,869 | +0.65% | 39,000 | 230億6040万 | +0.75% |
| 09/21 | 1,906 | 1,910 | 1,857 | 1,857 | -2.77% | 57,300 | 229億1234万 | +0.43% |
| 09/20 | 1,890 | 1,931 | 1,890 | 1,910 | +0.21% | 93,900 | 235億6627万 | +3.52% |
| 09/19 | 1,907 | 1,917 | 1,891 | 1,906 | -0.05% | 68,100 | 235億1692万 | +3.53% |
| 09/15 | 1,913 | 1,919 | 1,896 | 1,907 | -0.42% | 47,900 | 235億2926万 | +3.81% |
| 09/14 | 1,925 | 1,925 | 1,901 | 1,915 | -0.26% | 31,900 | 236億2796万 | +4.47% |
| 09/13 | 12:00 (開示事項の経過)当社子会社による独Evotec社との臨床用iPS細胞作製技術のライセンス契約に関するお知らせ |
| 09/13 | 1,894 | 1,926 | 1,894 | 1,920 | +0.63% | 56,400 | 236億8966万 | +5.09% |
| 09/12 | 1,897 | 1,917 | 1,891 | 1,908 | +1.27% | 55,300 | 235億4160万 | +4.72% |
| 09/11 | 1,889 | 1,893 | 1,867 | 1,884 | +0.27% | 35,700 | 232億4547万 | +3.63% |
| 09/08 | 1,875 | 1,888 | 1,870 | 1,879 | +0.75% | 52,900 | 231億8378万 | +3.53% |
| 09/07 | 1,866 | 1,886 | 1,857 | 1,865 | -0.32% | 44,000 | 230億1105万 | +2.81% |
| 09/06 | 1,853 | 1,876 | 1,853 | 1,871 | +1.03% | 47,000 | 230億8508万 | +3.14% |
| 09/05 | 1,839 | 1,854 | 1,829 | 1,852 | +0.98% | 49,600 | 228億5065万 | +2.04% |
| 09/04 | 1,840 | 1,846 | 1,827 | 1,834 | -0.11% | 24,700 | 226億2856万 | +0.94% |
| 09/01 | 1,814 | 1,837 | 1,814 | 1,836 | +0.82% | 31,600 | 226億5323万 | +0.82% |
| 08/31 | 1,834 | 1,846 | 1,811 | 1,821 | -0.6% | 59,100 | 224億6816万 | -0.22% |
| 08/30 | 1,850 | 1,854 | 1,830 | 1,832 | -0.65% | 40,200 | 226億388万 | +0.11% |
| 08/29 | 1,845 | 1,863 | 1,837 | 1,844 | +1.04% | 63,500 | 227億5194万 | +0.55% |
| 08/28 | 1,847 | 1,849 | 1,818 | 1,825 | -0.16% | 45,300 | 225億1751万 | -0.71% |
| 08/25 | 1,805 | 1,846 | 1,795 | 1,828 | +0.99% | 66,200 | 225億5453万 | -0.76% |
| 08/24 | 1,825 | 1,832 | 1,810 | 1,810 | -0.82% | 32,900 | 223億3244万 | -1.95% |
| 08/23 | 1,825 | 1,836 | 1,812 | 1,825 | 0% | 36,800 | 225億1751万 | -1.4% |
| 08/22 | 12:00 (開示事項の経過)当社子会社による京都大学iPS細胞研究財団(iPS財団)とのセンダイiPSの使用条件に関する覚書締結のお知らせ |
| 08/22 | 1,822 | 1,832 | 1,806 | 1,825 | +0.66% | 51,000 | 225億1751万 | -1.62% |
| 08/21 | 1,739 | 1,823 | 1,739 | 1,813 | +4.38% | 140,600 | 223億6945万 | -2.42% |
| 08/18 | 1,702 | 1,744 | 1,693 | 1,737 | +1.16% | 95,800 | 214億3174万 | -6.71% |
| 08/17 | 1,755 | 1,755 | 1,713 | 1,717 | -2.44% | 164,600 | 211億8497万 | -8.13% |
| 08/16 | 1,798 | 1,799 | 1,758 | 1,760 | -2.44% | 100,100 | 217億1552万 | -6.23% |
| 08/15 | 1,817 | 1,828 | 1,800 | 1,804 | -0.11% | 87,800 | 222億5841万 | -4.25% |
| 08/14 | 1,812 | 1,825 | 1,802 | 1,806 | +0.17% | 50,900 | 222億8308万 | -4.44% |
| 08/10 | 1,768 | 1,812 | 1,763 | 1,803 | +1.69% | 79,100 | 222億4607万 | -4.85% |
| 08/09 | 1,782 | 1,812 | 1,773 | 1,773 | -1.12% | 109,200 | 218億7592万 | -6.78% |
| 08/08 | 1,813 | 1,856 | 1,793 | 1,793 | -1.05% | 204,700 | 221億2268万 | -6.17% |
| 08/07 | 15:30 株式会社ワールドスキャンプロジェクトとのMedical web3時代のウェルビーイング実現に向けた戦略的パートナーシップ契約締結のお知らせ |
| 08/07 | 1,726 | 1,815 | 1,726 | 1,812 | -0.44% | 236,200 | 223億5711万 | -5.53% |
| 08/04 | 15:30 2024年3月期第1四半期決算短信〔日本基準〕(連結) |
| 08/04 | 1,815 | 1,828 | 1,792 | 1,820 | -0.66% | 124,900 | 224億5582万 | -5.41% |
| 08/03 | 1,860 | 1,862 | 1,832 | 1,832 | -1.82% | 74,100 | 226億388万 | -5.08% |
| 08/02 | 1,900 | 1,905 | 1,858 | 1,866 | -2.15% | 113,700 | 230億2338万 | -3.52% |
| 08/01 | 1,900 | 1,921 | 1,891 | 1,907 | -0.05% | 82,200 | 235億2926万 | -1.55% |
| 07/31 | 1,939 | 1,943 | 1,907 | 1,908 | -0.68% | 70,400 | 235億4160万 | -1.65% |
| 07/28 | 1,920 | 1,930 | 1,898 | 1,921 | -1.18% | 68,400 | 237億199万 | -1.08% |
| 07/27 | 1,944 | 1,953 | 1,903 | 1,944 | +0.15% | 75,100 | 239億8578万 | 0% |
| 07/26 | 1,925 | 1,945 | 1,923 | 1,941 | +0.31% | 19,100 | 239億4876万 | -0.21% |
| 07/25 | 1,949 | 1,949 | 1,930 | 1,935 | -0.31% | 28,500 | 238億7473万 | -0.57% |
| 07/24 | 1,935 | 1,953 | 1,930 | 1,941 | +0.73% | 58,800 | 239億4876万 | -0.31% |
| 07/21 | 1,919 | 1,936 | 1,917 | 1,927 | +0.1% | 21,400 | 237億7602万 | -1.03% |
| 07/20 | 1,926 | 1,940 | 1,920 | 1,925 | -0.52% | 21,000 | 237億5135万 | -1.03% |
| 07/19 | 1,937 | 1,937 | 1,924 | 1,935 | +0.52% | 23,800 | 238億7473万 | -0.51% |
| 07/18 | 1,909 | 1,925 | 1,905 | 1,925 | +1% | 31,000 | 237億5135万 | -0.98% |
| 07/14 | 1,929 | 1,930 | 1,897 | 1,906 | -0.47% | 45,100 | 235億1692万 | -2.01% |
| 07/13 | 1,908 | 1,924 | 1,901 | 1,915 | +0.42% | 34,400 | 236億2796万 | -1.49% |
| 07/12 | 1,944 | 1,944 | 1,906 | 1,907 | -0.83% | 59,200 | 235億2926万 | -1.85% |
| 07/11 | 1,950 | 1,962 | 1,922 | 1,923 | -0.57% | 36,100 | 237億2667万 | -1.03% |
| 07/10 | 1,930 | 1,945 | 1,919 | 1,934 | -0.31% | 32,500 | 238億6239万 | -0.46% |
| 07/07 | 1,939 | 1,966 | 1,924 | 1,940 | -0.46% | 45,000 | 239億3642万 | -0.15% |
| 07/06 | 1,951 | 1,961 | 1,935 | 1,949 | -1.32% | 37,900 | 240億4747万 | +0.36% |
| 07/05 | 1,979 | 1,990 | 1,967 | 1,975 | -0.65% | 33,400 | 243億6827万 | +1.8% |
| 07/04 | 1,969 | 1,989 | 1,952 | 1,988 | +0.81% | 33,700 | 245億2866万 | +2.63% |
| 07/03 | 16:00 取締役の役職および委嘱事項に関するお知らせ |
| 07/03 | 16:00 連結子会社の商号変更に関するお知らせ |
| 07/03 | 1,975 | 1,992 | 1,966 | 1,972 | +0.36% | 51,000 | 243億3125万 | +1.96% |
| 06/30 | 1,954 | 1,965 | 1,935 | 1,965 | +0.31% | 51,100 | 242億4488万 | +1.76% |
| 06/29 | 1,956 | 1,971 | 1,946 | 1,959 | +0.67% | 63,400 | 241億7085万 | +1.56% |
| 06/28 | 1,922 | 1,947 | 1,918 | 1,946 | +0.83% | 83,600 | 240億1045万 | +0.93% |
| 06/27 | 1,966 | 1,966 | 1,907 | 1,930 | -2.48% | 119,700 | 238億1304万 | +0.16% |
| 06/26 | 1,958 | 1,994 | 1,941 | 1,979 | +1.07% | 98,600 | 244億1762万 | +2.7% |
| 06/23 | 2,000 | 2,015 | 1,941 | 1,958 | -1.71% | 118,600 | 241億5851万 | +1.66% |
| 06/22 | 1,971 | 1,998 | 1,964 | 1,992 | +1.58% | 65,700 | 245億7802万 | +3.48% |
| 06/21 | 1,973 | 1,990 | 1,953 | 1,961 | -0.66% | 83,800 | 241億9553万 | +2.03% |
| 06/20 | 1,941 | 1,974 | 1,925 | 1,974 | +1.54% | 80,500 | 243億5593万 | +2.76% |
| 06/19 | 1,935 | 1,944 | 1,916 | 1,944 | +0.47% | 49,100 | 239億8578万 | +1.25% |
| 06/16 | 1,912 | 1,939 | 1,905 | 1,935 | +2.38% | 81,600 | 238億7473万 | +0.83% |
| 06/15 | 1,913 | 1,916 | 1,890 | 1,890 | -1.36% | 71,600 | 233億1950万 | -1.61% |
| 06/14 | 1,920 | 1,933 | 1,913 | 1,916 | -0.21% | 48,800 | 236億4030万 | -0.16% |
| 06/13 | 1,946 | 1,950 | 1,919 | 1,920 | -0.83% | 51,500 | 236億8966万 | +0.21% |
| 06/12 | 1,914 | 1,946 | 1,910 | 1,936 | +2.22% | 96,300 | 238億8707万 | +1.1% |
| 06/09 | 1,906 | 1,917 | 1,892 | 1,894 | +0.85% | 62,900 | 233億6886万 | -0.89% |
| 06/08 | 1,916 | 1,919 | 1,873 | 1,878 | -1.88% | 93,600 | 231億7144万 | -1.57% |
| 06/07 | 1,944 | 1,952 | 1,912 | 1,914 | -0.83% | 77,700 | 236億1563万 | +0.53% |
| 06/06 | 1,910 | 1,932 | 1,897 | 1,930 | +0.52% | 56,000 | 238億1304万 | +1.58% |
| 06/05 | 1,933 | 1,934 | 1,905 | 1,920 | -0.31% | 57,100 | 236億8966万 | +1.32% |
| 06/02 | 1,890 | 1,926 | 1,888 | 1,926 | +2.01% | 58,300 | 237億6369万 | +1.9% |
| 06/01 | 1,927 | 1,927 | 1,886 | 1,888 | -1.2% | 58,100 | 232億9483万 | +0.11% |
| 05/31 | 1,908 | 1,933 | 1,896 | 1,911 | +0.21% | 63,000 | 235億7861万 | +1.49% |
| 05/30 | 1,905 | 1,920 | 1,870 | 1,907 | +0.21% | 83,200 | 235億2926万 | +1.44% |
| 05/29 | 15:30 2023年3月期(第26期)決算説明資料 |
| 05/29 | 15:30 (開示事項の経過)当社子会社の臨床用iPS細胞作製技術の住友ファーマによる米国企業への再実施権行使のお知らせ |
| 05/29 | 1,934 | 1,934 | 1,902 | 1,903 | -1.09% | 57,200 | 234億7990万 | +1.39% |
| 05/26 | 1,931 | 1,937 | 1,918 | 1,924 | -0.31% | 40,900 | 237億3901万 | +2.61% |
| 05/25 | 1,945 | 1,945 | 1,915 | 1,930 | +0.36% | 54,100 | 238億1304万 | +3.1% |
| 05/24 | 18:00 当社子会社によるSTEMCELL Technologies社とのiPS細胞作製技術に関するライセンス契約締結のお知らせ |
| 05/24 | 1,916 | 1,940 | 1,908 | 1,923 | -0.31% | 42,500 | 237億2667万 | +2.89% |
| 05/23 | 17:35 役員人事に関するお知らせ |
| 05/23 | 1,957 | 1,970 | 1,916 | 1,929 | -0.52% | 93,900 | 238億70万 | +3.38% |
| 05/22 | 15:30 新型コロナウイルスワクチンの規定接種完了者を対象としたIRO-203追加接種(経鼻)第1相臨床試験開始のお知らせ |
| 05/22 | 1,925 | 1,949 | 1,924 | 1,939 | 0% | 44,300 | 239億2408万 | +4.14% |
| 05/19 | 1,928 | 1,944 | 1,912 | 1,939 | +0.41% | 75,800 | 239億2408万 | +4.3% |
| 05/18 | 1,946 | 1,946 | 1,910 | 1,931 | +0.36% | 85,700 | 238億2538万 | +4.04% |
| 05/17 | 1,945 | 1,950 | 1,918 | 1,924 | -1.03% | 85,800 | 237億3901万 | +3.89% |
| 05/11 | 15:30 2023年3月期決算短信〔日本基準〕(連結) |
| 05/11 | 15:30 剰余金の配当に関するお知らせ |
